Spencer Pharmaceutical Stock Performance
| SPPH Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Spencer Pharmaceutical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Spencer Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Spencer Pharmaceutical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 1:25 | Last Split Date 2009-10-05 |
1 | Orpyx technology selected for NIH-funded trial on diabetic foot ulcer prevention - Medical Economics | 11/14/2025 |
2 | Spencer Jakab Free Stock Trading Is Expensive - The Wall Street Journal | 12/03/2025 |
3 | Spencer s Retail Limited Stock Fails to Break Resistance Traders React - Support Zone Identification Superior Capital Trading - bollywoodhelpline.com | 12/29/2025 |
4 | Recovery Setup Building in Spencer s Retail Limited Experts Say - 2025 Sector Review Reliable Breakout Forecasts - ulpravda.ru | 01/08/2026 |
5 | Pharma Firm Boehringer Ingelheim Taps Spencer, Vergara For First Super Bowl Spot 01292026 - MediaPost | 01/29/2026 |
Spencer Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 0.01 in Spencer Pharmaceutical on November 8, 2025 and sell it today you would earn a total of 0.00 from holding Spencer Pharmaceutical or generate 0.0% return on investment over 90 days. Spencer Pharmaceutical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Spencer, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Spencer Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spencer Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spencer Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Spencer Pharmaceutical generated a negative expected return over the last 90 days | |
| Spencer Pharmaceutical has some characteristics of a very speculative penny stock | |
| Spencer Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| Spencer Pharmaceutical currently holds 2.91 M in liabilities. Spencer Pharmaceutical has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spencer Pharmaceutical's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (943.2 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Pharma Firm Boehringer Ingelheim Taps Spencer, Vergara For First Super Bowl Spot 01292026 - MediaPost |
Spencer Pharmaceutical Fundamentals Growth
Spencer Stock prices reflect investors' perceptions of the future prospects and financial health of Spencer Pharmaceutical, and Spencer Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spencer Stock performance.
| Return On Asset | -1.42 | ||||
| Current Valuation | 1.18 M | ||||
| Price To Book | 0.35 X | ||||
| Net Income | (943.2 K) | ||||
| Cash And Equivalents | 455.93 K | ||||
| Total Debt | 2.91 M | ||||
| Current Ratio | 0.28 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | 642.43 K | ||||
| Market Capitalization | 1.34 M | ||||
| Total Asset | 772.2 K | ||||
About Spencer Pharmaceutical Performance
By evaluating Spencer Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Spencer Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spencer Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spencer Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.18) | (0.19) | |
| Return On Capital Employed | 0.26 | 0.27 | |
| Return On Assets | (0.18) | (0.19) | |
| Return On Equity | (0.20) | (0.21) |
Things to note about Spencer Pharmaceutical performance evaluation
Checking the ongoing alerts about Spencer Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spencer Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spencer Pharmaceutical generated a negative expected return over the last 90 days | |
| Spencer Pharmaceutical has some characteristics of a very speculative penny stock | |
| Spencer Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| Spencer Pharmaceutical currently holds 2.91 M in liabilities. Spencer Pharmaceutical has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spencer Pharmaceutical's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (943.2 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Pharma Firm Boehringer Ingelheim Taps Spencer, Vergara For First Super Bowl Spot 01292026 - MediaPost |
- Analyzing Spencer Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spencer Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Spencer Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spencer Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spencer Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spencer Pharmaceutical's stock. These opinions can provide insight into Spencer Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spencer Stock analysis
When running Spencer Pharmaceutical's price analysis, check to measure Spencer Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spencer Pharmaceutical is operating at the current time. Most of Spencer Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Spencer Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spencer Pharmaceutical's price. Additionally, you may evaluate how the addition of Spencer Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |